← Back to Search

Antibiotic

Preoperative Antibiotics for Dental Implant Failure

Phase 1
Recruiting
Led By Robert Durand, DMD, MS
Research Sponsored by Université de Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week, 4 months, 1 year
Awards & highlights

Summary

This trial will study the effect of preoperative azithromycin on implant surgery outcomes. It is a double-masked, placebo-controlled, randomized clinical trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week, 4 months, 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week, 4 months, 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
peri-implant crestal bone change
Secondary outcome measures
anxiety
bleeding index
duration of surgery (minutes)
+19 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: TestActive Control1 Intervention
- 500mg of azithromycin one hour before implant placement
Group II: controlPlacebo Group1 Intervention
- identical placebo one hour before implant placement

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Centre de Recherche du Centre Hospitalier de l'Université de MontréalOTHER
52 Previous Clinical Trials
94,277 Total Patients Enrolled
Université de MontréalLead Sponsor
218 Previous Clinical Trials
103,048 Total Patients Enrolled
Robert Durand, DMD, MSPrincipal InvestigatorUniversité de Montréal
1 Previous Clinical Trials
42 Total Patients Enrolled

Media Library

Azithromycin (Antibiotic) Clinical Trial Eligibility Overview. Trial Name: NCT04280406 — Phase 1
Dental Implant Failure Research Study Groups: Test, control
Dental Implant Failure Clinical Trial 2023: Azithromycin Highlights & Side Effects. Trial Name: NCT04280406 — Phase 1
Azithromycin (Antibiotic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04280406 — Phase 1
~9 spots leftby Jul 2025